Shiru Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
26
- Latest Deal Type
-
Series 1
- Investors
-
32
Shiru General Information
Description
Provider of artificial intelligence-powered protein discovery and development services intended to create novel ingredients for food and consumer products. The company offers insights from AI, bioinformatics, and precision biology to discover natural proteins, enabling clients to replace harmful substances.
Contact Information
Website
www.shiru.comCorporate Office
- 1385 Ninth Street
- Berkeley, CA 94710
- United States
Corporate Office
- 1385 Ninth Street
- Berkeley, CA 94710
- United States
Shiru Timeline
Shiru Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC (Series 1) | 06-Feb-2026 | Completed | Generating Revenue | |||
| 9. Accelerator/Incubator | 12-Dec-2025 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series B) | 25-Feb-2025 | Completed | Generating Revenue | |||
| 7. Early Stage VC (Series A) | 27-Oct-2021 | Completed | Generating Revenue | |||
| 6. Grant | 01-Apr-2021 | Completed | Generating Revenue | |||
| 5. Grant | 22-Mar-2021 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 09-Oct-2020 | Completed | Generating Revenue | |||
| 3. Seed Round | 22-Oct-2019 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | $150K | Completed | Startup | |||
| 1. Accelerator/Incubator | 01-Jan-2019 | $150K | $150K | Completed | Startup |
Shiru Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-2 | ||||||||
| Series B-1 | ||||||||
| Series A | ||||||||
| Seed-3 | ||||||||
| Seed-2 | 348,031 | $0.000100 | $0.01 | $0.72 | $0.72 | 1x | $0.72 | 0.12% |
| Seed-1 | 876,632 | $0.000100 | $0 | $0.17 | $0.17 | 1x | $0.17 | 0.31% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Shiru Comparisons
Industry
Financing
Details
Shiru Competitors (8)
One of Shiru’s 8 competitors is Alpine Bio, a Venture Capital-Backed company based in San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Alpine Bio | Venture Capital-Backed | San Francisco, CA | ||||
| SYMATESE | Formerly PE-Backed | Chaponost, France | ||||
| Geltor | Venture Capital-Backed | Emeryville, CA | ||||
| Miruku | Venture Capital-Backed | Palmerston North, New Zealand | ||||
| Cytovance Biologics | Formerly PE-Backed | Oklahoma City, OK |
Shiru Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Shiru Patents
Shiru Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240390253-A1 | Climate change mitigation using oleogels prepared from plant proteins to replace animal derived fats and tropical oils in food products | Pending | 24-May-2023 | ||
| US-11896687-B1 | Oleogel having a protein microstructure with optimized oil release properties for replacing structured fats and saturated oils in food and cosmetic products | Active | 22-May-2023 | ||
| EP-4680035-A1 | Structured protein particulate in fibre or sheet form that forms oleogels and macrocolloids for replacing fats and thickeners in food and cosmetic products | Pending | 13-Mar-2023 | ||
| WO-2024192180-A1 | Structured protein particulate in fibre or sheet form that forms oleogels and macrocolloids for replacing fats and thickeners in food and cosmetic products | Inactive | 13-Mar-2023 | ||
| EP-4594485-A1 | Naturally occurring decarboxylase proteins with superior gelation properties for preparing foods and cosmetics | Pending | 29-Sep-2022 | C12N9/88 |
Shiru Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Shiru Investors (32)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ingredion | Corporation | Minority | ||
| pladis Foods | Accelerator/Incubator | |||
| Gaingels | Venture Capital | Minority | ||
| Good Startup | Venture Capital | Minority | ||
| Meach Cove Capital | Venture Capital | Minority |
Shiru FAQs
-
When was Shiru founded?
Shiru was founded in 2019.
-
Where is Shiru headquartered?
Shiru is headquartered in Berkeley, CA.
-
What is the size of Shiru?
Shiru has 26 total employees.
-
What industry is Shiru in?
Shiru’s primary industry is Biotechnology.
-
Is Shiru a private or public company?
Shiru is a Private company.
-
What is Shiru’s current revenue?
The current revenue for Shiru is .
-
How much funding has Shiru raised over time?
Shiru has raised $36.8M.
-
Who are Shiru’s investors?
Ingredion, pladis Foods, Gaingels, Good Startup, and Meach Cove Capital are 5 of 32 investors who have invested in Shiru.
-
Who are Shiru’s competitors?
Alpine Bio, SYMATESE, Geltor, Miruku, and Cytovance Biologics are some of the 8 competitors of Shiru.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
